The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Choksi Laboratories Ltd

Choksi Laboratories Ltd

BSE 526546 · NSE CHOKSILA · ISIN INE493D01013 · Group X · Active

Healthcare › Healthcare › Healthcare Services › Healthcare Service Provider

₹150.50

-0.17%

BSE close, 28 August 2026

Market cap

₹104.83 cr

0.7 cr shares · Micro cap

Free float

₹71.82 cr

as published

P/E · P/B

48.5× · 4.56×

EPS ₹3.10 · BV ₹33.00

FY25-26 rev / PAT

46.01 / 1.96

₹ cr, as filed

Filings, window

19

4 selected · 21%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹81.85 52-WK HIGH ₹229.45 ₹150.50 47% of range
Against 52-week high-34.4%
Against 52-week low+83.9%
Day change-0.17%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹3.10
Price / earnings48.55×
Price / book4.56×
Book value — derived, price ÷ P/B₹33.00
Return on equity9.39%
Operating margin27.36%
Net margin4.82%

Consistency check

P/B ÷ P/E, which must equal ROE
9.39%
ROE as published
9.39%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 12.06 0.58 0.84 27.36% 4.82%
Mar-26 · Q 12.82 1.03 1.47 28.92% 8.01%
FY25-26 46.01 1.96 2.82 28.47% 4.27%

Quarter on quarter

Revenue, quarter on quarter
-5.9%
Net profit, quarter on quarter
-43.7%
Operating margin, quarter on quarter
-156 bps

Disclosure profile 19 filings in the window

0 median 17.0 p75 · 25 sector max 52 19 58th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Change in Management2
Board Outcome1
Results1
Selected sub-total4
Procedural
Newspaper Publication5
AGM / EGM3
Board Meeting2
General2
Annual Report1
Compliance Certificate1
Other Update1
Procedural sub-total15
Total19

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

19 filings · 4 selected · busiest 2026-08-13

Filing rhythm · the twelve most recent

2026-08-142026-10-05

SelectedProcedural

Filings

19 in the window · 2 earlier on record

  1. 5 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Submission of compliance certificate under Regulation 74(5) of SEBI (DP) Regulation for the quarter ended 30.09.2026

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 25 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Submission of newspaper publication of Notice of Extra Ordinary General Meeting

    Company Update / Newspaper Publication View filing →

  3. 24 September 2026 ·

    AGM / EGM

    Intimation For Extra-Ordinary General Meeting Of The Company To Be Held On 17Th October, 2026 At 12:30 P.M. Via Virtual Mode

    Extra-Ordinary General Meeting of the company is scheduled to be held on Saturday, 17th October, 2026 at 12:30 p.m. through video conferencing/OAVM to transact the business as set out in ....

    AGM/EGM / EGM View filing →

  4. 18 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceedings of the 33rd Annual General Meeting held on 18.09.2026

    AGM/EGM / AGM View filing →

  5. 14 September 2026 ·

    Board Meeting

    Board Meeting Intimation for Board Meeting Dated 19.09.2026

    Choksi Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/09/2026 ,inter alia, to consider and approve 1. To consider and approve ....

    Board Meeting / Board Meeting View filing →

  6. 27 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Submission of newspaper clipping for the Notice of 33rd Annual General Meeting of the company

    Company Update / Newspaper Publication View filing →

  7. 27 August 2026 ·

    General

    Intimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository Participants

    Submission of intimation for dispatch of letter regarding notice of upcoming AGM to those shareholders whose email addresses are not registered with the company/RTA or depositories

    Company Update / General View filing →

  8. 25 August 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Submission of Annual Report for the F.Y. 2025-26

    Others / Reg. 34 (1) Annual Report View filing →

  9. 25 August 2026 ·

    AGM / EGM

    Submission Of Notice Convening 33Rd Annual General Meeting Of The Company

    Submission of Notice convening 33rd AGM of the company to be held on 18th September, 2026 at 12:30 p.m. through Video conference/Other Audio Visual means

    AGM/EGM / AGM View filing →

  10. 21 August 2026 ·

    General

    Intimation Under Regulation 30 For Inspection Of USFDA

    Intimation under Regulation 30 of SEBI (LODR) 2015 for inspection of USFDA

    Company Update / General View filing →

  11. 21 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Submission of newspaper clipping of information regarding 33rd Annual General Meeting of the company

    Company Update / Newspaper Publication View filing →

  12. 14 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper publication of unaudited financial result for the quarter ended 30th June, 2026

    Company Update / Newspaper Publication View filing →

  13. 13 August 2026 ·

    Change in Management

    Change in Management

    Reappointment of Internal Auditor for the F.Y. 2026-27

    Company Update / Change in Management View filing →

  14. 13 August 2026 ·

    Change in Management

    Change in Management

    Reappointment of Ms. Himika Choksi as Whole Time Director for further period of five year w.e.f 01.04.2027 subject to approval from shareholders in the ensuing AGM.

    Company Update / Change in Management View filing →

  15. 13 August 2026 ·

    Results

    Submission Of Financial Results For The Quarter Ended 30Th June 2026

    Considered and approved the unaudited financial results of the company for the quarter ended 30th June. 2026

    Result / Financial Results View filing →

  16. 13 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Board Meeting Held On 13.08.2026

    1. Considered and approved the Unaudited Financial Results for the Quarter ended on 30th June, 2026 along with the Limited review report; 2. Decided the date for closure of Register of ....

    Board Meeting / Outcome of Board Meeting View filing →

  17. 5 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Meeting Of Directors To Be Held On 13Th August, 2026

    Choksi Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve 1. To consider and approve ....

    Board Meeting / Board Meeting View filing →

  18. 4 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper publication of information regarding change of RTA

    Company Update / Newspaper Publication View filing →

  19. 3 August 2026 ·

    Other Update

    Change in RTA

    Intimation for change of RTA in pursuant to Regulation 30 of SEBI (LODR) 2015

    Company Update / Allotment of Warrants View filing →

RSS feed for Choksi Laboratories Ltd · the 50 most recent filings